Literature DB >> 26836804

Psoriasis and comorbidities. Epidemiological studies.

Alexander Egeberg1.   

Abstract

Psoriasis is a prevalent chronic inflammatory disease whose exact aetiology is not fully understood, but both genetic and environmental factors have been implicated in the onset and progression of the disease. At the skin level, psoriasis is characterized by localized or widespread thick raised silvery-white scaling and pruritic plaques and studies have shown that psoriasis negatively affects patients' quality of life, and depression occurs more often in patients with psoriasis. However, data have shown that psoriasis is a systemic disease which affects the joints, vasculature, and other tissues as well. Indeed, approximately one-third of patients with psoriasis develop psoriatic arthritis, and patients with severe psoriasis have a shortened life expectancy. Although our knowledge of the pathogenesis of psoriasis has advanced significantly in the past decade, as have the pharmacological treatment options which are now available, several important knowledge gaps remain. Many of the proinflammatory mediators involved in psoriasis have also been implicated in some central nervous system (CNS) diseases. However, studies on associations between psoriasis and CNS diseases are scarce. Based on nationwide registry data from the entire Danish population, the present thesis examined the associations between psoriasis and certain CNS diseases. The specific objectives of this work were to investigate the independent impact of depression on the risk of cardiovascular disease (CVD) in patients with psoriasis, the relationship between psoriasis and uveitis, and the risk of incident multiple sclerosis (MS) following the onset of psoriasis, respectively. The main results were a significantly increased risk of myocardial infarction, stroke, and CVD death in patients with psoriasis during stages of acute depression. Moreover, we found a bidirectional relationship between psoriasis and uveitis, where the occurrence of either disease significantly increased the risk of the other. Perhaps most notably, however, was that we found a psoriasis-severity dependent increased risk of MS. In conclusion, psoriasis was significantly associated with certain CNS diseases, and the risk of CVD was strongly associated with acute depression in these patients. These novel findings suggest an important link between psoriasis and CNS diseases, and high-light the necessity for a holistic approach to the diagnosis and treatment of patients with psoriasis.

Entities:  

Mesh:

Year:  2016        PMID: 26836804

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  8 in total

1.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

2.  Association between uveitis and psoriatic disease: a systematic review and Meta-analysis based on the evidence from cohort studies.

Authors:  Chao-Ran Li; Lang Chen; Long-Fei Wang; Bin Yan; You-Ling Liang; Jing Luo
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

3.  DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis.

Authors:  Ancor Sanz-Garcia; Alejandra Reolid; Laura H Fisas; Ester Muñoz-Aceituno; Mar Llamas-Velasco; Antonio Sahuquillo-Torralba; Rafael Botella-Estrada; Jorge García-Martínez; Raquel Navarro; Esteban Daudén; Francisco Abad-Santos; Maria C Ovejero-Benito
Journal:  Acta Derm Venereol       Date:  2021-05-04       Impact factor: 3.875

4.  Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.

Authors:  Joanna Salomon; Łukasz Matusiak; Danuta Nowicka-Suszko; Jacek C Szepietowski
Journal:  Mediators Inflamm       Date:  2017-08-28       Impact factor: 4.711

5.  Aging in psoriasis vulgaris: female patients are epigenetically older than healthy controls.

Authors:  Pavel Borsky; Marcela Chmelarova; Zdenek Fiala; Kvetoslava Hamakova; Vladimir Palicka; Jan Krejsek; Ctirad Andrys; Jan Kremlacek; Vit Rehacek; Martin Beranek; Andrea Malkova; Tereza Svadlakova; Drahomira Holmannova; Lenka Borska
Journal:  Immun Ageing       Date:  2021-03-03       Impact factor: 6.400

6.  Psoriasis, Is It a Microdamage of Our "Sixth Sense"? A Neurocentric View.

Authors:  Balázs Sonkodi
Journal:  Int J Mol Sci       Date:  2022-10-08       Impact factor: 6.208

7.  A nationwide population-based cohort study of the incidence of severe and rare infections among adults with psoriasis in Denmark.

Authors:  Nikolai Loft; Lone Skov; Craig Richardson; Vivek Trivedi; Ivette Alarcon; Alexander Egeberg
Journal:  Br J Dermatol       Date:  2022-05-22       Impact factor: 11.113

8.  Increased Risk of Atrial Fibrillation and Thromboembolism in Patients with Severe Psoriasis: a Nationwide Population-based Study.

Authors:  Tae-Min Rhee; Ji Hyun Lee; Eue-Keun Choi; Kyung-Do Han; HyunJung Lee; Chan Soon Park; Doyeon Hwang; So-Ryoung Lee; Woo-Hyun Lim; Si-Hyuck Kang; Myung-Jin Cha; Youngjin Cho; Il-Young Oh; Seil Oh
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.